Search This Site

Search this Site

Genomics

March 30, 2016

 

Did you ever think about your genetic tendency to develop cancer or a chronic degenerative condition? Let’s take the case of Angelina Jolie Pitt: Diary of a Surgery and Angelina Jolie’s Round Two With Mutated BRCA1: Solid Science Sprinkled With Nonsense. She was positive for the BRAC–1 gene predisposing her to breast and ovarian cancer. She chose to do what she thought was best for herself. Statistics will show that of women with the BRAC–1 gene only 70 to 80% of these will develop breast cancer during their lifetime. Why not the other 20 to 30%? It has to do with the environment. There are things in our daily life that can cause these gene mutations to become active and cause cancer. This relates to not only lifestyle, but toxicity and chemical and hormone imbalance. If you knew your risk, how does this affect you? From a preventive standpoint, it tells me how you can be more aggressive in prevention and control the environment that switches the gene to cause cancer. This is more than just blindly taking supplements. Why shoot in the dark when you can have a detailed road map to look at your risk? I have a contact with the best genetic testing available today. A simple blood test will define your risk for up to 256 cancers and 30 chronic and degenerative conditions. At this time insurance does not cover this. What is the cost if this can give direction for preventative health measures? In addition, I also have available an early detection test for patients who have a diagnosis of cancer. This is called the circulating tumor cell test. Please read about it in the next two articles ClearID – A new tool to monitor breast cancer survivors and ClearID – A new tool for monitoring breast cancer recurrence. This is more sensitive than other blood tests and conventional medicine imaging testing. All of this information simply defines your risk and gives black and white data points that can help develop a better road map as far as what can be done on a preventive basis. None of these tests interfere with conventional medicine but help give guidelines as far as how aggressive and what other measures can be done to keep these cancer genes from turning on and becoming active.

Posted in Blog by jbosiljevac

Leave a Comment